← All trials
NCT00380770
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2003
- Primary completion
- Feb 1, 2009
- Completion date
- Mar 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 112
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of Kwa-Zulu NatalLead sponsor
- National Research Foundation, SingaporeCollaborator
- AIDS Malignancy ConsortiumCollaborator
- AIDS Care Research in AfricaCollaborator
- Dermatological Society of South AfricaCollaborator
- CiplaCollaborator
- University of Kwa-Zulu NatalOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.